523 related articles for article (PubMed ID: 19038308)
81. Structure and function of human 17beta-hydroxysteroid dehydrogenases.
Lukacik P; Kavanagh KL; Oppermann U
Mol Cell Endocrinol; 2006 Mar; 248(1-2):61-71. PubMed ID: 16414178
[TBL] [Abstract][Full Text] [Related]
82. Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cells.
van de Ven J; Donker GH; Sprong M; Blankenstein MA; Thijssen JH
J Steroid Biochem Mol Biol; 2002 Jul; 81(3):237-47. PubMed ID: 12163135
[TBL] [Abstract][Full Text] [Related]
83. A 3D QSAR model of 17beta-HSD1 inhibitors based on a thieno[2,3-d]pyrimidin-4(3H)-one core applying molecular dynamics simulations and ligand-protein docking.
Karkola S; Lilienkampf A; Wähälä K
ChemMedChem; 2008 Mar; 3(3):461-72. PubMed ID: 18224704
[TBL] [Abstract][Full Text] [Related]
84. Improved synthesis of EM-1745, preparation of its C17-ketone analogue and comparison of their inhibitory potency on 17beta-hydroxysteroid dehydrogenase type 1.
Bérubé M; Poirier D
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):832-43. PubMed ID: 19003559
[TBL] [Abstract][Full Text] [Related]
85. 17 beta-hydroxysteroid oxidoreductase activity in intact cells significantly differs from classical enzymology analysis.
Castagnetta LA; Granata OM; Taibi G; Lo Casto M; Comito L; Oliveri G; Di Falco M; Carruba G
J Endocrinol; 1996 Sep; 150 Suppl():S73-8. PubMed ID: 8943790
[TBL] [Abstract][Full Text] [Related]
86. Cloning, expression and characterization of three types of 17beta-hydroxysteroid dehydrogenases from the Nile tilapia, Oreochromis niloticus.
Zhou LY; Wang DS; Senthilkumaran B; Yoshikuni M; Shibata Y; Kobayashi T; Sudhakumari CC; Nagahama Y
J Mol Endocrinol; 2005 Aug; 35(1):103-16. PubMed ID: 16087725
[TBL] [Abstract][Full Text] [Related]
87. Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors.
Jansson A; Gunnarsson C; Stål O
Endocr Relat Cancer; 2006 Sep; 13(3):875-84. PubMed ID: 16954436
[TBL] [Abstract][Full Text] [Related]
88. Expression of 17beta-hydroxysteroid dehydrogenase type 2 and type 5 in breast cancer and adjacent non-malignant tissue: a correlation to clinicopathological parameters.
Han B; Li S; Song D; Poisson-Paré D; Liu G; Luu-The V; Ouellet J; Li S; Labrie F; Pelletier G
J Steroid Biochem Mol Biol; 2008 Dec; 112(4-5):194-200. PubMed ID: 18996480
[TBL] [Abstract][Full Text] [Related]
89. Structure-activity study in the class of 6-(3'-hydroxyphenyl)naphthalenes leading to an optimization of a pharmacophore model for 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitors.
Marchais-Oberwinkler S; Frotscher M; Ziegler E; Werth R; Kruchten P; Messinger J; Thole H; Hartmann RW
Mol Cell Endocrinol; 2009 Mar; 301(1-2):205-11. PubMed ID: 18950679
[TBL] [Abstract][Full Text] [Related]
90. Regulation of sex steroid formation by interleukin-4 and interleukin-6 in breast cancer cells.
Turgeon C; Gingras S; Carrière MC; Blais Y; Labrie F; Simard J
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):151-62. PubMed ID: 9699868
[TBL] [Abstract][Full Text] [Related]
91. A new nonestrogenic steroidal inhibitor of 17β-hydroxysteroid dehydrogenase type I blocks the estrogen-dependent breast cancer tumor growth induced by estrone.
Ayan D; Maltais R; Roy J; Poirier D
Mol Cancer Ther; 2012 Oct; 11(10):2096-104. PubMed ID: 22914440
[TBL] [Abstract][Full Text] [Related]
92. Aromatase, estrone sulfatase, and 17β-hydroxysteroid dehydrogenase: structure-function studies and inhibitor development.
Hong Y; Chen S
Mol Cell Endocrinol; 2011 Jul; 340(2):120-6. PubMed ID: 20888390
[TBL] [Abstract][Full Text] [Related]
93. Role, control and expression of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase activities in human breast cancer.
Pasqualini JR
Zentralbl Gynakol; 1997; 119 Suppl 2():48-53. PubMed ID: 9361395
[TBL] [Abstract][Full Text] [Related]
94. A challenge for medicinal chemistry by the 17β-hydroxysteroid dehydrogenase superfamily: an integrated biological function and inhibition study.
Lin SX; Poirier D; Adamski J
Curr Top Med Chem; 2013; 13(10):1164-71. PubMed ID: 23647539
[TBL] [Abstract][Full Text] [Related]
95. Inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Brozic P; Lanisnik Risner T; Gobec S
Curr Med Chem; 2008; 15(2):137-50. PubMed ID: 18220769
[TBL] [Abstract][Full Text] [Related]
96. Dissection of the physiological interconversion of 5alpha-DHT and 3alpha-diol by rat 3alpha-HSD via transient kinetics shows that the chemical step is rate-determining: effect of mutating cofactor and substrate-binding pocket residues on catalysis.
Heredia VV; Penning TM
Biochemistry; 2004 Sep; 43(38):12028-37. PubMed ID: 15379543
[TBL] [Abstract][Full Text] [Related]
97. 17 beta-hydroxysteroid dehydrogenases--their role in pathophysiology.
Vihko P; Härkönen P; Soronen P; Törn S; Herrala A; Kurkela R; Pulkka A; Oduwole O; Isomaa V
Mol Cell Endocrinol; 2004 Feb; 215(1-2):83-8. PubMed ID: 15026178
[TBL] [Abstract][Full Text] [Related]
98. Discovery of a non-estrogenic irreversible inhibitor of 17β-hydroxysteroid dehydrogenase type 1 from 3-substituted-16β-(m-carbamoylbenzyl)-estradiol derivatives.
Maltais R; Ayan D; Trottier A; Barbeau X; Lagüe P; Bouchard JE; Poirier D
J Med Chem; 2014 Jan; 57(1):204-22. PubMed ID: 24328103
[TBL] [Abstract][Full Text] [Related]
99. Design, synthesis, biological evaluation and pharmacokinetics of bis(hydroxyphenyl) substituted azoles, thiophenes, benzenes, and aza-benzenes as potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1).
Bey E; Marchais-Oberwinkler S; Werth R; Negri M; Al-Soud YA; Kruchten P; Oster A; Frotscher M; Birk B; Hartmann RW
J Med Chem; 2008 Nov; 51(21):6725-39. PubMed ID: 18855374
[TBL] [Abstract][Full Text] [Related]
100. Steroidal lactones as inhibitors of 17beta-hydroxysteroid dehydrogenase type 5: chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities.
Bydal P; Luu-The V; Labrie F; Poirier D
Eur J Med Chem; 2009 Feb; 44(2):632-44. PubMed ID: 18472187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]